{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:43:20Z","timestamp":1781257400516,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Commuting time to treatment has been shown to affect healthcare outcomes such as engagement and initiation. The purpose of this study is to extend this line of research to investigate the effects of driving time to opioid programs on treatment outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed discharge survey data from 22,587 outpatient opioid use disorder treatment episodes (mainly methadone) in Los Angeles County and estimated the associated driving time to each episode using Google Maps. We used multivariable logistic regressions to examine the association between estimated driving time and odds of treatment completion after adjusting for possible confounders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Findings show an average driving time of 11.32\u2009min and an average distance of 11.18\u2009km. We observed differences in estimated driving time across age, gender, and socioeconomic status. Young, male, more formally educated, and Medi-Cal-ineligible clients drove longer to treatment. A 10-min drive was associated with a 33% reduction in the completion of methadone treatment plans (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This systemwide analysis provides novel time estimates of driving-based experiences and a strong relationship with completion rates in methadone treatment. Specifically, the result showing reduced treatment completion rates for drive times longer than 10\u2009min may inform policies regarding the ideal geographic placement of methadone-based treatment programs and service expansion initiatives.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-022-07886-7","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T10:04:06Z","timestamp":1649671446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study"],"prefix":"10.1186","volume":"22","author":[{"given":"Abdullah","family":"Alibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenie","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"7886_CR1","volume-title":"Drug overdose deaths in the U.S. top 100,000 annually","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. Drug overdose deaths in the U.S. top 100,000 annually: National Center for Health Statistics; 2021. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm. Accessed 10 Mar 2022"},{"key":"7886_CR2","first-page":"200","volume":"63","author":"A Srivastava","year":"2017","unstructured":"Srivastava A, Kahan M, Nader M. Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone? Can Fam Physician. 2017;63:200\u20135.","journal-title":"Can Fam Physician"},{"key":"7886_CR3","doi-asserted-by":"publisher","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","volume":"3","author":"WC Goedel","year":"2020","unstructured":"Goedel WC, Shapiro A, Cerd\u00e1 M, Tsai JW, Hadland SE, Marshall BDL. Association of Racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3:e203711.","journal-title":"JAMA Netw Open"},{"key":"7886_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiatry. 2019;76:979\u201381.","journal-title":"JAMA Psychiatry"},{"key":"7886_CR5","volume-title":"Access to addiction services differs by race and gender","author":"National Institute on Drug Abuse","year":"2019","unstructured":"National Institute on Drug Abuse. Access to addiction services differs by race and gender: National Institute on Drug Abuse; 2019. https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2019\/07\/access-to-addiction-services-differs-by-race-gender. Accessed 31 May 2021"},{"key":"7886_CR6","volume-title":"The opioid crisis and the black\/African American population: an urgent issue","author":"Substance Abuse and Mental Health Services Administration","year":"2020","unstructured":"Substance Abuse and Mental Health Services Administration. The opioid crisis and the black\/African American population: an urgent issue. Rockville: U.S. Department of Health and Human Services; 2020."},{"key":"7886_CR7","doi-asserted-by":"publisher","first-page":"e0250324","DOI":"10.1371\/journal.pone.0250324","volume":"16","author":"A Hyder","year":"2021","unstructured":"Hyder A, Lee J, Dundon A, Southerland LT, All D, Hammond G, et al. Opioid treatment deserts: concept development and application in a US Midwestern urban county. Plos One. 2021;16:e0250324.","journal-title":"Plos One"},{"key":"7886_CR8","doi-asserted-by":"crossref","unstructured":"Ogneva-Himmelberger Y. Spatial Analysis of Drug Poisoning Deaths and Access to Substance-use Disorder Treatment in the United States. In:  Proceedings of the 5th International Conference on Geographical Information Systems Theory, Applications and Management - HGIS. Heraklion: SciTePress; 2019. p. 315\u201321.","DOI":"10.5220\/0007828703150321"},{"key":"7886_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3109\/10826080903443602","volume":"45","author":"BE Perron","year":"2010","unstructured":"Perron BE, Gillespie DF, Alexander-Eitzman B, Delva J. Availability of outpatient substance use disorder treatment programs in the United States. Subst Use Misuse. 2010;45:1097\u2013111.","journal-title":"Subst Use Misuse"},{"key":"7886_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugpo.2012.04.004","volume":"24","author":"EG Guerrero","year":"2013","unstructured":"Guerrero EG, Kao D, Perron BE. Travel distance to outpatient substance use disorder treatment facilities for Spanish-speaking clients. Int J Drug Policy. 2013;24:38\u201345.","journal-title":"Int J Drug Policy."},{"key":"7886_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0740-5472(03)00188-0","volume":"25","author":"K Beardsley","year":"2003","unstructured":"Beardsley K, Wish ED, Fitzelle DB, O\u2019Grady K, Arria AM. Distance traveled to outpatient drug treatment and client retention. J Subst Abus Treat. 2003;25:279\u201385.","journal-title":"J Subst Abus Treat"},{"key":"7886_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2020.1624","volume":"77","author":"RA Kleinman","year":"2020","unstructured":"Kleinman RA. Comparison of driving times to opioid treatment programs and pharmacies in the US. JAMA Psychiatry. 2020;77:1163\u201371.","journal-title":"JAMA Psychiatry"},{"key":"7886_CR13","doi-asserted-by":"publisher","first-page":"108727","DOI":"10.1016\/j.drugalcdep.2021.108727","volume":"224","author":"S Amiri","year":"2021","unstructured":"Amiri S, Hirchak K, McDonell MG, Denney JT, Buchwald D, Amram O. Access to medication-assisted treatment in the United States: comparison of travel time to opioid treatment programs and office-based buprenorphine treatment. Drug Alcohol Depend. 2021;224:108727.","journal-title":"Drug Alcohol Depend"},{"key":"7886_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00952990.2019.1620261","volume":"46","author":"S Amiri","year":"2020","unstructured":"Amiri S, Lutz RB, McDonell MG, Roll JM, Amram O. Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment. Am J Drug Alcohol Abuse. 2020;46:78\u201387.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"7886_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09687637.2016.1189875","volume":"25","author":"JL Klinger","year":"2018","unstructured":"Klinger JL, Karriker-Jaffe KJ, Witbrodt J, Kaskutas LA. Effects of distance to treatment on subsequent alcohol consumption. Drugs Educ Prev Policy. 2018;25:173\u201380.","journal-title":"Drugs Educ Prev Policy"},{"key":"7886_CR16","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1038\/s41598-021-87407-4","volume":"11","author":"H Barbosa","year":"2021","unstructured":"Barbosa H, Hazarie S, Dickinson B, Bassolas A, Frank A, Kautz H, et al. Uncovering the socioeconomic facets of human mobility. Sci Rep. 2021;11:8616.","journal-title":"Sci Rep"},{"key":"7886_CR17","doi-asserted-by":"publisher","first-page":"102905","DOI":"10.1016\/j.jtrangeo.2020.102905","volume":"90","author":"C Costa","year":"2021","unstructured":"Costa C, Ha J, Lee S. Spatial disparity of income-weighted accessibility in Brazilian cities: application of a Google maps API. J Transp Geogr. 2021;90:102905.","journal-title":"J Transp Geogr"},{"key":"7886_CR18","doi-asserted-by":"publisher","first-page":"102762","DOI":"10.1016\/j.jtrangeo.2020.102762","volume":"86","author":"A D\u0117del\u0117","year":"2020","unstructured":"D\u0117del\u0117 A, Mi\u0161kinyt\u0117 A, Andru\u0161aityt\u0117 S, Nemani\u016bt\u0117-Gu\u017eien\u0117 J. Dependence between travel distance, individual socioeconomic and health-related characteristics, and the choice of the travel mode: a cross-sectional study for Kaunas, Lithuania. J Transp Geogr. 2020;86:102762.","journal-title":"J Transp Geogr"},{"key":"7886_CR19","first-page":"11","volume":"5","author":"BA Graves","year":"2008","unstructured":"Graves BA. Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes. Perspect Health Inf Manag AHIMA Am Health Inf Manag Assoc. 2008;5:11.","journal-title":"Perspect Health Inf Manag AHIMA Am Health Inf Manag Assoc"},{"key":"7886_CR20","doi-asserted-by":"publisher","first-page":"e013059","DOI":"10.1136\/bmjopen-2016-013059","volume":"6","author":"C Kelly","year":"2016","unstructured":"Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. 2016;6:e013059.","journal-title":"BMJ Open"},{"key":"7886_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/19427867.2019.1584694","volume":"12","author":"Z Qi","year":"2020","unstructured":"Qi Z, Lim S, Hossein RT. Assessment of transport equity to central Business District (CBD) in Sydney. Australia Transp Lett. 2020;12:246\u201356.","journal-title":"Australia Transp Lett"},{"key":"7886_CR22","unstructured":"County Of Los Angeles Enterprise GIS. 2010 Census data by block, vol. 2010: LA County eGIS Program. https:\/\/egis-lacounty.hub.arcgis.com\/datasets\/lacounty::2010-census-data-by-block\/about. Accessed 1 Nov 2021"},{"key":"7886_CR23","volume-title":"Google Maps Platform","author":"Google Developers","year":"2021","unstructured":"Google Developers. Google maps distance matrix API. In:  Google Maps Platform; 2021. https:\/\/developers.google.com\/maps\/documentation\/distance-matrix\/start. Accessed 1 Nov 2021."},{"key":"7886_CR24","unstructured":"ESRI. Create Drive-Time Areas. ArcGIS Online Help | Documentation. https:\/\/doc.arcgis.com\/en\/arcgis-online\/analyze\/create-drive-time-areas.htm. Accessed 8 Feb 2022."},{"key":"7886_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.healthplace.2013.08.008","volume":"24","author":"L Mao","year":"2013","unstructured":"Mao L, Nekorchuk D. Measuring spatial accessibility to healthcare for populations with multiple transportation modes. Health Place. 2013;24:115\u201322.","journal-title":"Health Place"},{"key":"7886_CR26","volume-title":"Treatment episode data set (TEDS): 2017. Admissions to and discharges from publicly-funded substance use treatment","author":"Substance Abuse and Mental Health","year":"2019","unstructured":"Substance Abuse and Mental Health. Treatment episode data set (TEDS): 2017. Admissions to and discharges from publicly-funded substance use treatment. Rockville: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2019."},{"key":"7886_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1747-597X-7-34","volume":"7","author":"EG Guerrero","year":"2012","unstructured":"Guerrero EG, Campos M, Urada D, Yang JC. Do cultural and linguistic competence matter in Latinos\u2019 completion of mandated substance abuse treatment? Subst Abuse Treat Prev Policy. 2012;7:34.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"7886_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.addbeh.2012.05.006","volume":"37","author":"EG Guerrero","year":"2012","unstructured":"Guerrero EG, Cepeda A, Duan L, Kim T. Disparities in completion of substance abuse treatment among Latino subgroups in Los Angeles County, CA. Addict Behav. 2012;37:1162\u20136.","journal-title":"Addict Behav"},{"key":"7886_CR29","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/1475-6773.12031","volume":"48","author":"EG Guerrero","year":"2013","unstructured":"Guerrero EG, Marsh JC, Duan L, Oh C, Perron B, Lee B. Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res. 2013;48:1450\u201367.","journal-title":"Health Serv Res"},{"key":"7886_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.drugalcdep.2013.03.015","volume":"132","author":"S Arndt","year":"2013","unstructured":"Arndt S, Acion L, White K. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend. 2013;132:547\u201354.","journal-title":"Drug Alcohol Depend"},{"key":"7886_CR31","doi-asserted-by":"publisher","first-page":"108028","DOI":"10.1016\/j.jsat.2020.108028","volume":"114","author":"MS Askari","year":"2020","unstructured":"Askari MS, Martins SS, Mauro PM. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: differences in retention and completion among opioid-related discharges in 2016. J Subst Abus Treat. 2020;114:108028.","journal-title":"J Subst Abus Treat"},{"key":"7886_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addbeh.2019.01.041","volume":"93","author":"J Mennis","year":"2019","unstructured":"Mennis J, Stahler GJ, El Magd SA, Baron DA. How long does it take to complete outpatient substance use disorder treatment? Disparities among blacks, Hispanics, and whites in the US. Addict Behav. 2019;93:158\u201365.","journal-title":"Addict Behav"},{"key":"7886_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","volume":"190","author":"GJ Stahler","year":"2018","unstructured":"Stahler GJ, Mennis J. Treatment outcome disparities for opioid users: are there racial and ethnic differences in treatment completion across large US metropolitan areas? Drug Alcohol Depend. 2018;190:170\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"7886_CR34","volume-title":"The TEDS report: predictors of substance abuse treatment completion or transfer to further treatment, by service type","author":"Substance Abuse and Mental Health Services Administration","year":"2009","unstructured":"Substance Abuse and Mental Health Services Administration. The TEDS report: predictors of substance abuse treatment completion or transfer to further treatment, by service type. Rockville: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2009."},{"key":"7886_CR35","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2021","unstructured":"R Core Team. R: A language and environment for statistical computing: R Foundation for Statistical Computing; 2021. https:\/\/www.R-project.org\/. Accessed 1 Nov 2021"},{"key":"7886_CR36","doi-asserted-by":"publisher","first-page":"e948789","DOI":"10.1155\/2011\/948789","volume":"2011","author":"A Rosenblum","year":"2011","unstructured":"Rosenblum A, Cleland CM, Fong C, Kayman DJ, Tempalski B, Parrino M. Distance traveled and cross-state commuting to opioid treatment programs in the United States. J Environ Public Health. 2011;2011:e948789.","journal-title":"J Environ Public Health"},{"key":"7886_CR37","volume-title":"Car access: everyone needs reliable transportation access and in most American communities that means a car","author":"National Equity Atlas","year":"2019","unstructured":"National Equity Atlas. Car access: everyone needs reliable transportation access and in most American communities that means a car. 2019. https:\/\/nationalequityatlas.org\/indicators\/Car_access#\/?geo=01000000000000000. Accessed 17 Aug 2021."},{"key":"7886_CR38","volume-title":"It\u2019s about time: the transit time penalty and its racial implications undefined","author":"Neighborhoods organizing for change, TakeAction Minnesota, ISAIAH, the Center for Popular Democracy","year":"2015","unstructured":"Neighborhoods organizing for change, TakeAction Minnesota, ISAIAH, the Center for Popular Democracy. It\u2019s about time: the transit time penalty and its racial implications undefined 2015."},{"key":"7886_CR39","volume-title":"Commuting by public transportation in the United States: 2019","author":"U.S. Census Bureau","year":"2021","unstructured":"U.S. Census Bureau. Commuting by public transportation in the United States: 2019. 2021."},{"key":"7886_CR40","doi-asserted-by":"publisher","first-page":"102948","DOI":"10.1016\/j.drugpo.2020.102948","volume":"86","author":"EG Guerrero","year":"2020","unstructured":"Guerrero EG, Alibrahim A, Howard DL, Wu S, D\u2019Aunno T. Stability in a large drug treatment system: examining the role of program size and performance on service discontinuation. Int J Drug Policy. 2020;86:102948.","journal-title":"Int J Drug Policy"}],"updated-by":[{"DOI":"10.1186\/s12913-022-07993-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000}}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-07886-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-07886-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-07886-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T08:09:04Z","timestamp":1652083744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-07886-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7886"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-07886-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12913-022-07993-5","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12913-022-07993-5","URL":"https:\/\/doi.org\/10.1186\/s12913-022-07993-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at the University of Chicago reviewed the study protocol and approved this study (IRB18\u20131657). We confirm that all methods were carried out in accordance with relevant guidelines and regulations. We also confirm that all experimental protocols were approved by a Institutional Review Board at the University of Chicago and the National Institutes for Health. We confirm that no human experiments were conducted in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}